Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prostate cancer
Pharma
J&J PARP combo Akeega nabs new FDA nod in prostate cancer niche
Akeega is the first precision medicine combo that can treat patients with BRCA2-mutated metastatic castration-sensitive prostate cancer.
Zoey Becker
Dec 15, 2025 12:14pm
Novartis' Pluvicto slows progression in earlier prostate cancer
Oct 19, 2025 10:30am
ClevelandDx reboots campaign to drive prostate cancer screening
Aug 27, 2025 9:30am
Novartis' Pluvicto picks up speed, delivers another trial win
Jul 17, 2025 10:56am
Pfizer, Astellas' Xtandi combo extends life in early prostate cancer
Jul 10, 2025 11:52am
FDA approves use of Bayer's Nubeqa in all patients with mCSPC
Jun 4, 2025 11:38am
